GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Kimia Biosciences Ltd

Kimia Biosciences Ltd Q4 & FY26 Financial Results Published

RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 01 Jun 2026, 06:18 PM IST  ·  BSE ID: 083deed9-570e-4de1-8525-3cf687e3ade7
View Original BSE Filing (PDF)
💡
In Simple Terms
The company announced its financial performance for the final quarter and the entire year ending March 2026.
🤖 AI Summary
  • Kimia Biosciences Ltd published Audited Financial Results (Standalone) for Q4 and year ended March 31, 2026.
  • Total Income was Rs. 2,644.23 Lacs for Q4 FY26 and Rs. 10,804.54 Lacs for the full FY26.
  • Net Profit stood at Rs. 544.15 Lacs for the quarter ended March 31, 2026.
  • Full year Net Profit was Rs. 1,991.70 Lacs for the fiscal year 2025-2026.
  • The Board of Directors approved these results on May 29, 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Total Income (Quarter ended March 31, 2026)
Rs. 2,644.23 Lacs
Net Profit (Quarter ended March 31, 2026)
Rs. 544.15 Lacs
Total Income (Year ended March 31, 2026)
Rs. 10,804.54 Lacs
Net Profit (Year ended March 31, 2026)
Rs. 1,991.70 Lacs
Basic EPS (Year ended March 31, 2026)
Rs. 4.21
🏢 How This Affects the Company
💰
Financial Impact
The company reported a Total Income of Rs. 10,804.54 Lacs and a Net Profit of Rs. 1,991.70 Lacs for the fiscal year ended March 31, 2026. This data establishes the company's financial base for the disclosed period.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this financial results publication.
👤
Who Is Affected
All shareholders are affected by the company's financial performance as it reflects the underlying business health for the reported periods.
🔍
Management Signal
The publication of audited results reflects management's adherence to regulatory disclosure requirements under Regulation 47 of SEBI LODR.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q1 FY27 financial results — assess sequential revenue and profit trends.
Future board meeting outcomes — check for any strategic business decisions.
Subsequent regulatory filings — monitor for any operational or expansion updates.
LOW RISK This filing is a standard financial disclosure, presenting historical data without indicating new specific risks.
💡 Investor Takeaway
Kimia Biosciences Ltd reported a Total Income of Rs. 10,804.54 Lacs and Net Profit of Rs. 1,991.70 Lacs for the year ended March 31, 2026. For Q4 FY26, Total Income was Rs. 2,644.23 Lacs and Net Profit was Rs. 544.15 Lacs. No comparable prior period data is available.
⚖️ Strengths & Concerns

✅ Positives

  • Total Income for the fiscal year ended March 31, 2026, reached Rs. 10,804.54 Lacs, demonstrating revenue generation capacity.
  • Net Profit for the full fiscal year 2025-2026 was reported at Rs. 1,991.70 Lacs, indicating profitable operations for the period.

⚠️ Concerns

  • No comparable prior period financial data is provided in the filing to assess quarter-on-quarter or year-on-year performance trends.
  • Detailed segment-wise or geographic-wise revenue breakdown is not available within the disclosed financial results.
❓ Frequently Asked Questions
What was Kimia Biosciences Ltd's Total Income for the quarter ended March 31, 2026?
Kimia Biosciences Ltd reported a Total Income of Rs. 2,644.23 Lacs for the quarter ended March 31, 2026.
What was Kimia Biosciences Ltd's Net Profit for the year ended March 31, 2026?
The Net Profit for Kimia Biosciences Ltd for the fiscal year ended March 31, 2026, was Rs. 1,991.70 Lacs.
When were Kimia Biosciences Ltd's Q4 and FY26 financial results approved?
The Audited Financial Results for the quarter and year ended March 31, 2026, were considered and approved by the Board of Directors on May 29, 2026.
What was Kimia Biosciences Ltd's Basic EPS for the year ended March 31, 2026?
Kimia Biosciences Ltd reported a Basic EPS of Rs. 4.21 for the year ended March 31, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.